Antimicrobial Use and Antimicrobial Resistance: A Population Perspective
暂无分享,去创建一个
[1] Y. Carmeli,et al. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] A. Tomasz,et al. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. , 2001, Pediatrics.
[3] L. Leibovici,et al. Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link. , 2001, The Journal of antimicrobial chemotherapy.
[4] M. Lipsitch,et al. The rise and fall of antimicrobial resistance. , 2001, Trends in microbiology.
[5] L H Moulton,et al. Design of a group-randomized Streptococcus pneumoniae vaccine trial. , 2001, Controlled clinical trials.
[6] C Peña,et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. , 2001, JAMA.
[7] T. Crabtree,et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit , 2001, Critical care medicine.
[8] J. Blumer,et al. Nosocomial acquisition and transmission of antibiotic-resistant Gram-negative organisms in the pediatric intensive care unit , 2001, The Pediatric infectious disease journal.
[9] D. Livermore,et al. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction , 2001, The Lancet.
[10] M. Lipsitch,et al. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Y. Carmeli,et al. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] L. Rice,et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. , 2000, The New England journal of medicine.
[13] S. Schrag,et al. Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. , 2000, Clinical microbiology reviews.
[14] Rustom Antia,et al. Effects of Antiviral Usage on Transmission Dynamics of Herpes Simplex Virus Type 1 and on Antiviral Resistance: Predictions of Mathematical Models , 2000, Antimicrobial Agents and Chemotherapy.
[15] B. Levin,et al. Concentration-Dependent Selection of Small Phenotypic Differences in TEM β-Lactamase-Mediated Antibiotic Resistance , 2000, Antimicrobial Agents and Chemotherapy.
[16] M. Lipsitch,et al. Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model. , 2000, Vaccine.
[17] P. Farmer,et al. Redefining MDR-TB transmission 'hot spots'. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[18] R. J. Hayes,et al. Design and analysis issues in cluster-randomized trials of interventions against infectious diseases , 2000, Statistical methods in medical research.
[19] Carl T. Bergstrom,et al. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] K Henry,et al. The Case for More Cautious, Patient-Focused Antiretroviral Therapy , 2000, Annals of Internal Medicine.
[21] J. John. Antibiotic Cycling: Is It Ready for Prime Time? , 2000, Infection Control & Hospital Epidemiology.
[22] L. Rice,et al. The Microbial Genetics of Antibiotic Cycling , 2000, Infection Control & Hospital Epidemiology.
[23] Y. Carmeli,et al. Control Group Selection Is an Important but Neglected Issue in Studies of Antibiotic Resistance , 2000, Annals of Internal Medicine.
[24] D. Livermore,et al. Epidemiology of antibiotic resistance , 2000, Intensive Care Medicine.
[25] Y. Carmeli,et al. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. , 1999, Archives of internal medicine.
[26] I. Phillips. Assessing the evidence that antibiotic growth promoters influence human infections. , 1999, The Journal of hospital infection.
[27] B. Levin,et al. The biological cost of antibiotic resistance. , 1999, Current opinion in microbiology.
[28] Widdowson Ca,et al. Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. , 1999 .
[29] Estimation of the direct and indirect effects of vaccination. , 1999, Statistics in medicine.
[30] J S Koopman,et al. Individual causal models and population system models in epidemiology. , 1999, American journal of public health.
[31] R. Anderson,et al. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[32] G. Eliopoulos,et al. Colonization with broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection. , 1999, Critical care medicine.
[33] R. Anderson,et al. Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[34] Valérie Buthion,et al. ColoNav: patient navigation for colorectal cancer screening in deprived areas – Study protocol , 1999, BMC Cancer.
[35] R. Anderson,et al. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[36] K. Klugman,et al. Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. , 1999, Seminars in respiratory infections.
[37] R. Hayes,et al. Simple sample size calculation for cluster-randomized trials. , 1999, International journal of epidemiology.
[38] J. Burke. Antibiotic resistance--squeezing the balloon? , 1998, JAMA.
[39] S. Blower,et al. Predicting and preventing the emergence of antiviral drug resistance in HSV-2 , 1998, Nature Medicine.
[40] A. Ambergen,et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. , 1998, Archives of internal medicine.
[41] L. Corey,et al. Perspectives on switching oral acyclovir from prescription to over-the-counter status: report of a consensus panel. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] S. Hammer,et al. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. , 1997, JAMA.
[43] M Kakehashi,et al. The transmission dynamics of antibiotic–resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption , 1997, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[44] M E Halloran,et al. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. , 1997, American journal of epidemiology.
[45] S Bonhoeffer,et al. Evaluating treatment protocols to prevent antibiotic resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[46] M. Kollef,et al. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. , 1997, American journal of respiratory and critical care medicine.
[47] F. M. Stewart,et al. The population genetics of antibiotic resistance. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[48] S. Blower,et al. Control Strategies for Tuberculosis Epidemics: New Models for Old Problems , 1996, Science.
[49] J. Boyce,et al. Treatment and Control of Colonization in the Prevention of Nosocomial Infections , 1996, Infection Control & Hospital Epidemiology.
[50] I M Longini,et al. The ecological effects of individual exposures and nonlinear disease dynamics in populations. , 1994, American journal of public health.
[51] J. Robins,et al. Invited commentary: ecologic studies--biases, misconceptions, and counterexamples. , 1994, American journal of epidemiology.
[52] M. Samore,et al. Clostridium difficile colonization and diarrhea at a tertiary care hospital. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[53] M E Halloran,et al. Study designs for dependent happenings. , 1991, Epidemiology.
[54] M E Halloran,et al. Direct and indirect effects in vaccine efficacy and effectiveness. , 1991, American journal of epidemiology.
[55] A. Garber,et al. A discrete-time model of the acquisition of antibiotic-resistant infections in hospitalized patients. , 1989, Biometrics.
[56] F Lemaire,et al. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. , 1989, Annals of internal medicine.
[57] J. Mcgowan. Minimizing Antimicrobial Resistance in Hospital Bacteria: Can Switching or Cycling Drugs Help? , 1986, Infection Control.
[58] D. Waaij. Antibiotic choice : the importance of colonisation resistance , 1983 .
[59] S. Levin,et al. Selection of Intermediate Rates of Increase in Parasite-Host Systems , 1981, The American Naturalist.
[60] L. Dunkle,et al. Eradication of epidemic methicillin-gentamicin-resistant staphylococcus aureus in an intensive care nursery. , 1981, The American journal of medicine.
[61] H. Maibach,et al. BACTERIAL INTERFERENCE BETWEEN STRAINS OF S. aureus , 1974, Annals of the New York Academy of Sciences.
[62] S. Erill. Letter: Cycloserine and tuberulous meningitis. , 1973, Lancet.
[63] D. Price,et al. Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics. , 1970, Lancet.
[64] G. Hardin,et al. The Tragedy of the Commons , 1968, Green Planet Blues.
[65] G Hardin,et al. The tragedy of the commons. The population problem has no technical solution; it requires a fundamental extension in morality. , 1968, Science.